Make your drug development a success!

Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development.
PhinC Services
News

They trust us

Agnes Hemon
Agnes Hemon
Preclinical and P.K clinical Officer - HRA Pharma
PhinC is one of HRA Pharma’s valuable partners for pharmacokinetic studies. From just an advice to modelling, we know we can trust them to efficiently support and carry out our projects.
John DiBella
John DiBella
President, Lancaster Division - Simulations Plus, Inc. (NASDAQ: SLP)
Simulations Plus has formed a strong relationship with PhinC as we work together to drive increased adoption of physiologically-based pharmacokinetic (PBPK) modeling to support pharmaceutical research and development. Their talented team of scientists have become proficient users of our GastroPlus™ software platform, and we are confident that the services they provide to clients are valuable and greatly impact R&D productivity.
French Tech Paris-Saclay
Club Phase 1
GMP - Groupe de Métabolisme et Pharmacocinétique
EUFEMED
AFSSI
MabDesign